Neuropathic pain after femoropopliteal bypass surgery

Greiner, A. S.; Rantner, Barbara; Greiner, Kathrin; Kronenberg, Florian; Schocke, Michael; Neuhauser, Beate; Bodner, Johannes; Fraedrich, G.; Schlager, Andreas

doi:10.1016/j.jvs.2004.02.003

Cited by 9 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Up to 60–80% of amputees experience phantom pain after amputation (3), and breast surgery is followed by chronic pain in 20–50% of patients (4). A similar high percentage of patients develop chronic pain after thoracotomy (5), sternotomy (6) and femoropopliteal bypass surgery (7). Common operations, such as gallbladder surgery, inguinal hernia repair and Cesarean section, may also lead to chronic pain in approximately 12–30% of patients (8–10).…”

mentioning

confidence: 99%

Chronic pain following total hip arthroplasty: a nationwide questionnaire study

Nikolajsen

Brandsborg

Lucht

et al. 2006

Acta Anaesthesiol Scand

247

181

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Chronic pain following total hip arthroplasty: a nationwide questionnaire study

Nikolajsen

Brandsborg

Lucht

et al. 2006

Acta Anaesthesiol Scand

247

181

View full text Add to dashboard Cite

show abstract

“…16 Neuropathic pain persists in surgical incision sites in 24% of patients after 1 year. 17 In critical limb ischemia, FP bypass with the use of a venous conduit has a 5-year patency of ≈66%, dropping to 33% when polytetrafluoroethylene (PTFE) graft material is used and the distal anastomosis is below the knee. 18 Few studies have compared surgical bypass with endovascular therapy.…”

Section: More Is Lessmentioning

confidence: 99%

Drug-Eluting Stents Are the Default Strategy for Superficial Femoral Artery Intervention Now

Burket

2016

Circulation

View full text Add to dashboard Cite

“…But other studies have reported 1-year CPSP prevalence rates as high as 39% [39] and 45% [40]. Rates of CPSP following vascular surgery are similar in range (25%), with moderate to severe pain typically presenting along the femoropopliteal bypass tunnel [42]. …”

Section: Introductionmentioning

confidence: 99%

Technology-Enabled Remote Monitoring and Self-Management — Vision for Patient Empowerment Following Cardiac and Vascular Surgery: User Testing and Randomized Controlled Trial Protocol

McGillion¹,

Yost²,

Turner³

et al. 2016

JMIR Res Protoc

View full text Add to dashboard Cite

BackgroundTens of thousands of cardiac and vascular surgeries (CaVS) are performed on seniors in Canada and the United Kingdom each year to improve survival, relieve disease symptoms, and improve health-related quality of life (HRQL). However, chronic postsurgical pain (CPSP), undetected or delayed detection of hemodynamic compromise, complications, and related poor functional status are major problems for substantial numbers of patients during the recovery process. To tackle this problem, we aim to refine and test the effectiveness of an eHealth-enabled service delivery intervention, TecHnology-Enabled remote monitoring and Self-MAnagemenT—VIsion for patient EmpoWerment following Cardiac and VasculaR surgery (THE SMArTVIEW, CoVeRed), which combines remote monitoring, education, and self-management training to optimize recovery outcomes and experience of seniors undergoing CaVS in Canada and the United Kingdom.ObjectiveOur objectives are to (1) refine SMArTVIEW via high-fidelity user testing and (2) examine the effectiveness of SMArTVIEW via a randomized controlled trial (RCT).MethodsCaVS patients and clinicians will engage in two cycles of focus groups and usability testing at each site; feedback will be elicited about expectations and experience of SMArTVIEW, in context. The data will be used to refine the SMArTVIEW eHealth delivery program. Upon transfer to the surgical ward (ie, post-intensive care unit [ICU]), 256 CaVS patients will be reassessed postoperatively and randomly allocated via an interactive Web randomization system to the intervention group or usual care. The SMArTVIEW intervention will run from surgical ward day 2 until 8 weeks following surgery. Outcome assessments will occur on postoperative day 30; at week 8; and at 3, 6, 9, and 12 months. The primary outcome is worst postop pain intensity upon movement in the previous 24 hours (Brief Pain Inventory-Short Form), averaged across the previous 14 days. Secondary outcomes include a composite of postoperative complications related to hemodynamic compromise—death, myocardial infarction, and nonfatal stroke— all-cause mortality and surgical site infections, functional status (Medical Outcomes Study Short Form-12), depressive symptoms (Geriatric Depression Scale), health service utilization-related costs (health service utilization data from the Institute for Clinical Evaluative Sciences data repository), and patient-level cost of recovery (Ambulatory Home Care Record). A linear mixed model will be used to assess the effects of the intervention on the primary outcome, with an a priori contrast of weekly average worst pain intensity upon movement to evaluate the primary endpoint of pain at 8 weeks postoperation. We will also examine the incremental cost of the intervention compared to usual care using a regression model to estimate the difference in expected health care costs between groups.ResultsStudy start-up is underway and usability testing is scheduled to begin in the fall of 2016.ConclusionsGiven our experience, dedicated industry partners, an...

show abstract

Neuropathic pain after femoropopliteal bypass surgery

Cited by 9 publications

References 13 publications

Chronic pain following total hip arthroplasty: a nationwide questionnaire study

Chronic pain following total hip arthroplasty: a nationwide questionnaire study

Drug-Eluting Stents Are the Default Strategy for Superficial Femoral Artery Intervention Now

Technology-Enabled Remote Monitoring and Self-Management — Vision for Patient Empowerment Following Cardiac and Vascular Surgery: User Testing and Randomized Controlled Trial Protocol

Contact Info

Product

Resources

About